Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of July 2026, with the report dated July 2, 2026. The filing primarily serves to notify shareholders of a Special General Meeting scheduled for August 6, 2026, and to disclose a recent amendment to warrant terms.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding corporate governance and does not contain financial statements or performance data.
Material Changes
- Warrant Amendment: On June 17, 2026, the Company entered into a Warrant Amendment Agreement with a holder of certain warrants. The amended terms require shareholder approval at the upcoming Special General Meeting.
- Correction of Prior Filing: The Company re-filed the Warrant Amendment Agreement as Exhibit 10.1 to correct a typographical error found in the version previously filed on June 18, 2026 (Exhibit 10.3).
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors. The primary contingency noted is the requirement for shareholder approval of the warrant amendment terms at the Special General Meeting. The filing is incorporated by reference into the Company's active Registration Statements on Form F-3 and Form S-8.
Investor Verification Checklist
- Verify the specific terms of the Warrant Amendment Agreement detailed in Exhibit 99.2 (Proxy Statement).
- Confirm the record date for voting eligibility, which is the close of business on July 9, 2026.
- Review the corrected Warrant Amendment Agreement (Exhibit 10.1) to understand the nature of the typographical error corrected from the June 18 filing.
- Check the outcome of the Special General Meeting scheduled for August 6, 2026, regarding the approval of the warrant amendment.